Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,948 | 204 | 99.1% |
| Gift | $26.68 | 29 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $763.00 | 52 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $317.51 | 18 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $282.22 | 20 | $0 (2020) |
| Allergan, Inc. | $271.85 | 27 | $0 (2020) |
| Janssen Biotech, Inc. | $228.02 | 17 | $0 (2021) |
| Novum Pharma, LLC | $202.93 | 35 | $0 (2017) |
| UCB, Inc. | $95.56 | 5 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $95.06 | 8 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $91.32 | 6 | $0 (2021) |
| Braintree Laboratories, Inc. | $82.29 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $29.21 | 1 | ABBVIE INC. ($29.21) |
| 2021 | $440.26 | 28 | AbbVie Inc. ($129.02) |
| 2020 | $302.62 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($55.40) |
| 2019 | $622.50 | 33 | AbbVie, Inc. ($223.75) |
| 2018 | $507.14 | 43 | AbbVie, Inc. ($119.54) |
| 2017 | $1,072 | 109 | AbbVie, Inc. ($245.94) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/13/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Gastroenterology | ||||||
| 08/03/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Immunology | ||||||
| 07/13/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Immunology | ||||||
| 06/16/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/01/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 05/26/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| Category: GI | ||||||
| 05/25/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU, UCERIS | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Gastroenterology | ||||||
| 05/12/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/11/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Immunology | ||||||
| 04/09/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/07/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: GI | ||||||
| 04/06/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/31/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU, XIFAXAN | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Gastroenterology | ||||||
| 03/30/2021 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUTAB | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 03/24/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU, UCERIS | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Gastroenterology | ||||||
| 03/01/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 320 | 402 | $108,350 | $27,145 |
| 2020 | 7 | 463 | 593 | $179,675 | $39,979 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 198 | 280 | $42,000 | $15,697 | 37.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 39 | 39 | $7,800 | $2,889 | 37.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 33 | 33 | $23,100 | $2,780 | 12.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $16,800 | $2,307 | 13.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 20 | 20 | $15,500 | $2,064 | 13.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $3,150 | $1,408 | 44.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 253 | 380 | $57,000 | $18,381 | 32.2% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 51 | 51 | $39,525 | $6,400 | 16.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 44 | 47 | $32,900 | $3,997 | 12.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 64 | 64 | $12,800 | $3,971 | 31.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 16 | 16 | $22,400 | $3,135 | 14.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 17 | 17 | $11,900 | $3,020 | 25.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 18 | $3,150 | $1,073 | 34.1% |
About Dr. John Kniaz, DO
Dr. John Kniaz, DO is a Gastroenterology healthcare provider based in Munster, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659470110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kniaz, DO has received a total of $2,974 in payments from pharmaceutical and medical device companies, with $29.21 received in 2022. These payments were reported across 233 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,948).
As a Medicare-enrolled provider, Kniaz has provided services to 783 Medicare beneficiaries, totaling 995 services with total Medicare billing of $67,123. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Munster, IN
- Active Since 09/21/2006
- Last Updated 08/13/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1659470110
Products in Payments
- Humira (Biological) $395.86
- XIFAXAN (Drug) $267.32
- Entyvio (Biological) $235.04
- LINZESS (Drug) $216.89
- Alcortin A (Drug) $145.06
- HUMIRA (Biological) $144.29
- STELARA (Biological) $142.07
- Mavyret (Drug) $98.60
- Cimzia (Drug) $95.56
- Linzess (Drug) $91.32
- REMICADE (Biological) $85.95
- VIBERZI (Drug) $84.44
- MOTOFEN (Drug) $71.21
- Creon (Drug) $61.59
- GATTEX (Drug) $60.28
- ALINIA (Drug) $42.92
- Dexilant (Drug) $40.71
- ZENPEP (Drug) $37.83
- Novacort (Drug) $36.79
- Motegrity (Drug) $34.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Munster
Dr. Gene Chang, M.d, M.D
Gastroenterology — Payments: $16,634
Dr. Navin Kumar, Md, MD
Gastroenterology — Payments: $15,094
David Herbstman, Md, MD
Gastroenterology — Payments: $4,336
Hadi Atassi, D.o, D.O
Gastroenterology — Payments: $3,682
Dr. Joel Cahan, Md, MD
Gastroenterology — Payments: $3,255
Sarah Zubair, Md, MD
Gastroenterology — Payments: $906.70